{"result": "{\n    \"title\": \"Pediatric Amino Acid Solutions Community\",\n    \"summary\": \"The community focuses on pediatric amino acid solutions, including Aminoplasmal Paed® 10%, Aminoven Infant® 10%, and Primene® 10%. These entities are interconnected through their roles in parenteral nutrition for children, highlighting their importance in pediatric healthcare.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical role these amino acid solutions play in the nutritional support of vulnerable pediatric populations.\",\n    \"findings\": [\n        {\n            \"summary\": \"Aminoplasmal Paed® 10% as a key solution\",\n            \"explanation\": \"Aminoplasmal Paed® 10% is a significant entity in this community, specifically designed for pediatric parenteral nutrition. Its formulation is tailored to meet the unique nutritional needs of children, making it essential for those unable to receive adequate nutrition through oral means. The relationships it has with various amino acids, such as L-Tirosina and L-Lisina, further emphasize its comprehensive approach to pediatric care. This solution is crucial for supporting growth and development in infants and children who require specialized nutritional interventions [Data: Entities (5169); Relationships (704, 6390, 6382, 6383, 6384, +more)].\"\n        },\n        {\n            \"summary\": \"Aminoven Infant® 10% and its role in infant nutrition\",\n            \"explanation\": \"Aminoven Infant® 10% is another vital entity in this community, specifically formulated for infants requiring parenteral nutrition. This solution is designed to provide essential amino acids that are critical for the growth and development of infants, particularly those who are premature or have specific medical conditions. The relationships it maintains with amino acids like L-ISOLEUCINA and L-VALINA highlight its importance in ensuring that infants receive the necessary nutrients for healthy development. The presence of this solution in pediatric care settings underscores the community's focus on addressing the nutritional needs of the youngest patients [Data: Entities (5167); Relationships (702, 6358, 6365, 6366, 6369, +more)].\"\n        },\n        {\n            \"summary\": \"Primene® 10% and its significance in pediatric care\",\n            \"explanation\": \"Primene® 10% is a critical solution within this community, utilized for pediatric patients requiring amino acid supplementation through parenteral nutrition. Its formulation includes essential amino acids that are vital for metabolic processes and overall health in children. The relationships it has with amino acids such as L-FENILALANINA and L-LEUCINA demonstrate its comprehensive nutritional profile. The inclusion of Primene® 10% in pediatric care highlights the community's commitment to providing effective nutritional support for children with diverse health needs [Data: Entities (5168); Relationships (703, 6374, 6371, 6372, 6375, +more)].\"\n        },\n        {\n            \"summary\": \"The role of amino acids in pediatric nutrition\",\n            \"explanation\": \"Amino acids such as L-TIROSINA, L-ALANINA, and L-CISTEÍNA are integral components of pediatric amino acid solutions, playing a significant role in the nutritional guidelines for children. These amino acids are essential for various physiological functions, including protein synthesis and metabolic regulation. Their inclusion in pediatric formulations underscores the importance of tailored nutritional strategies to support the health and development of children, particularly those with specific dietary needs. The community's focus on these amino acids reflects a broader commitment to enhancing pediatric healthcare through specialized nutrition [Data: Entities (5180, 5181, 5179); Relationships (6148, 6149, 6147, 6391, 6361, +more)].\"\n        },\n        {\n            \"summary\": \"Interconnectedness of pediatric amino acid solutions\",\n            \"explanation\": \"The relationships among Aminoplasmal Paed® 10%, Aminoven Infant® 10%, and Primene® 10% illustrate a network of interconnected solutions that collectively address the nutritional needs of pediatric patients. Each solution complements the others by providing a range of essential amino acids tailored to different age groups and medical conditions. This interconnectedness enhances the community's ability to provide comprehensive nutritional support, ensuring that children receive the appropriate care based on their specific health requirements. The collaborative nature of these solutions is vital for optimizing pediatric nutrition [Data: Relationships (704, 702, 703)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n5169,AMINOPLASMAL PAED® 10%,Aminoplasmal Paed® 10% es una solución de aminoácidos pediátricos diseñada para la nutrición parenteral en niños.,13\r\n5167,AMINOVEN INFANT® 10%,Aminoven Infant® 10% es una solución de aminoácidos pediátricos utilizada en nutrición parenteral para infantes.,13\r\n5168,PRIMENE® 10%,Primene® 10% es otra solución de aminoácidos pediátricos utilizada en nutrición parenteral.,11\r\n5180,L-TIROSINA,\"L-Tirosina is an amino acid that is present in pediatric amino acid solutions. It is also referenced in nutritional guidelines, particularly in its acetylated form. This highlights its significance in both medical and nutritional contexts, emphasizing its role in supporting health, especially in pediatric care.\",4\r\n5181,L-ALANINA,\"L-Alanina is an amino acid that is included in both pediatric amino acid formulas and nutritional recommendations for pediatric patients. This essential nutrient plays a significant role in the dietary needs of children, ensuring they receive adequate amino acids for growth and development.\",3\r\n5179,L-CISTEÍNA,L-Cisteína es un aminoácido que se incluye en las fórmulas de aminoácidos pediátricos.,3\r\n5170,L-ISOLEUCINA,L-Isoleucina es un aminoácido esencial que se encuentra en las soluciones de aminoácidos pediátricos.,3\r\n5171,L-LEUCINA,L-Leucina es un aminoácido esencial presente en las soluciones de aminoácidos pediátricos.,3\r\n5172,L-LISINA,L-Lisina es un aminoácido esencial que se incluye en las fórmulas de aminoácidos pediátricos.,3\r\n5173,L-METIONINA,L-Metionina es un aminoácido esencial que forma parte de las soluciones de aminoácidos pediátricos.,3\r\n5174,L-FENILALANINA,L-Fenilalanina es un aminoácido esencial que se encuentra en las soluciones de aminoácidos pediátricos.,3\r\n5175,L-TREONINA,L-Treonina es un aminoácido esencial presente en las soluciones de aminoácidos pediátricos.,3\r\n5176,L-TRIPTÓFANO,L-Triptófano es un aminoácido esencial que se incluye en las fórmulas de aminoácidos pediátricos.,3\r\n5177,L-VALINA,L-Valina es un aminoácido esencial que forma parte de las soluciones de aminoácidos pediátricos.,3\r\n5178,L-HISTIDINA,L-Histidina es un aminoácido que se encuentra en las soluciones de aminoácidos pediátricos.,3\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n704,NUTRICIÓN PARENTERAL,AMINOPLASMAL PAED® 10%,Aminoplasmal Paed® 10% es una solución utilizada en nutrición parenteral,263\r\n702,NUTRICIÓN PARENTERAL,AMINOVEN INFANT® 10%,Aminoven Infant® 10% es una solución utilizada en nutrición parenteral para infantes,263\r\n703,NUTRICIÓN PARENTERAL,PRIMENE® 10%,Primene® 10% es una solución utilizada en nutrición parenteral,261\r\n6148,NUTRICIÓN PEDIÁTRICA,L-TIROSINA,NUTRICIÓN PEDIÁTRICA includes guidelines on the intake of amino acids such as L-Tirosina,181\r\n6149,NUTRICIÓN PEDIÁTRICA,L-ALANINA,NUTRICIÓN PEDIÁTRICA includes guidelines on the intake of amino acids such as L-Alanina,180\r\n6147,NUTRICIÓN PEDIÁTRICA,L-CISTEÍNA,NUTRICIÓN PEDIÁTRICA includes guidelines on the intake of amino acids such as L-Cisteína,180\r\n6390,AMINOPLASMAL PAED® 10%,L-TIROSINA,L-Tirosina es un aminoácido presente en Aminoplasmal Paed® 10%,17\r\n6368,AMINOVEN INFANT® 10%,L-TIROSINA,L-Tirosina es un aminoácido presente en Aminoven Infant® 10%,17\r\n6380,AMINOPLASMAL PAED® 10%,L-ISOLEUCINA,L-Isoleucina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6381,AMINOPLASMAL PAED® 10%,L-LEUCINA,L-Leucina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6382,AMINOPLASMAL PAED® 10%,L-LISINA,L-Lisina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6383,AMINOPLASMAL PAED® 10%,L-METIONINA,L-Metionina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6384,AMINOPLASMAL PAED® 10%,L-FENILALANINA,L-Fenilalanina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6385,AMINOPLASMAL PAED® 10%,L-TREONINA,L-Treonina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6386,AMINOPLASMAL PAED® 10%,L-TRIPTÓFANO,L-Triptófano es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6387,AMINOPLASMAL PAED® 10%,L-VALINA,L-Valina es un aminoácido esencial presente en Aminoplasmal Paed® 10%,16\r\n6388,AMINOPLASMAL PAED® 10%,L-HISTIDINA,L-Histidina es un aminoácido presente en Aminoplasmal Paed® 10%,16\r\n6389,AMINOPLASMAL PAED® 10%,L-CISTEÍNA,L-Cisteína es un aminoácido presente en Aminoplasmal Paed® 10%,16\r\n6391,AMINOPLASMAL PAED® 10%,L-ALANINA,L-Alanina es un aminoácido presente en Aminoplasmal Paed® 10%,16\r\n6358,AMINOVEN INFANT® 10%,L-ISOLEUCINA,L-Isoleucina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6359,AMINOVEN INFANT® 10%,L-LEUCINA,L-Leucina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6360,AMINOVEN INFANT® 10%,L-LISINA,L-Lisina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6361,AMINOVEN INFANT® 10%,L-METIONINA,L-Metionina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6362,AMINOVEN INFANT® 10%,L-FENILALANINA,L-Fenilalanina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6363,AMINOVEN INFANT® 10%,L-TREONINA,L-Treonina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6364,AMINOVEN INFANT® 10%,L-TRIPTÓFANO,L-Triptófano es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6365,AMINOVEN INFANT® 10%,L-VALINA,L-Valina es un aminoácido esencial presente en Aminoven Infant® 10%,16\r\n6366,AMINOVEN INFANT® 10%,L-HISTIDINA,L-Histidina es un aminoácido presente en Aminoven Infant® 10%,16\r\n6367,AMINOVEN INFANT® 10%,L-CISTEÍNA,L-Cisteína es un aminoácido presente en Aminoven Infant® 10%,16\r\n6369,AMINOVEN INFANT® 10%,L-ALANINA,L-Alanina es un aminoácido presente en Aminoven Infant® 10%,16\r\n6379,PRIMENE® 10%,L-TIROSINA,L-Tirosina es un aminoácido presente en Primene® 10%,15\r\n6374,PRIMENE® 10%,L-FENILALANINA,L-Fenilalanina es un aminoácido esencial presente en Primene® 10%,14\r\n6378,PRIMENE® 10%,L-HISTIDINA,L-Histidina es un aminoácido presente en Primene® 10%,14\r\n6370,PRIMENE® 10%,L-ISOLEUCINA,L-Isoleucina es un aminoácido esencial presente en Primene® 10%,14\r\n6371,PRIMENE® 10%,L-LEUCINA,L-Leucina es un aminoácido esencial presente en Primene® 10%,14\r\n6372,PRIMENE® 10%,L-LISINA,L-Lisina es un aminoácido esencial presente en Primene® 10%,14\r\n6373,PRIMENE® 10%,L-METIONINA,L-Metionina es un aminoácido esencial presente en Primene® 10%,14\r\n6375,PRIMENE® 10%,L-TREONINA,L-Treonina es un aminoácido esencial presente en Primene® 10%,14\r\n6376,PRIMENE® 10%,L-TRIPTÓFANO,L-Triptófano es un aminoácido esencial presente en Primene® 10%,14\r\n6377,PRIMENE® 10%,L-VALINA,L-Valina es un aminoácido esencial presente en Primene® 10%,14\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}